U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...

Bank Nifty snaps 2-day gains after hitting record high; index set for longest weekly ...

Analysts expect banks' credit growth to improve due to demand uptick following rate cuts, see stable asset quality as a ...

U.S. FDA Approves PADCEV(R) plus Keytruda(R) for Certain Patients with Bladder Cancer

(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...

Inside UK pet cloning trend where desperate Brits pay £50k to resurrect ‘zombie dogs ...

ANYONE who has lost a beloved pet knows the heartrending grief that brings – and how you would do anything to bring them back ...

MF scheme launches surge 12% YoY, large companies still dominate industry AUM

Between October 2024 and October 2025, all scheme categories showed strong growth. Equity schemes led thewith an increase ...

ASX jumps 1.2pc in Nvidia-fuelled tech rally; Liontown soars

Shares rally after Nvidia result; Ellison to stay on at MinRes for now; UBS ups gold forecast; DroneShield defends share sale; Liontown upbeat after first auction; Magellan’s top stockpicker resigns.